CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Nofi Michael Chief Financial Officer | Sale | −4,442 | $45.43 | $202K | 6,495 |
| 2026-08-13 | Donovan Joanne M. CMO | Sale | −2,919 | $43.41 | $127K | 8,625 |
| 2026-08-12 | Russell Alan J Chief Scientific Officer | Sale | −3,238 | $43.68 | $141K | 34,129 |
| 2026-08-12 | Russell Alan J Chief Scientific Officer | Sale | −2,273 | $43.68 | $99K | 31,856 |
| 2026-08-12 | Russell Alan J Chief Scientific Officer | Sale | −390 | $44.46 | $17K | 31,466 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −2,171 | $43.79 | $95K | 34,755 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −304 | $44.50 | $14K | 34,451 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −150 | $44.44 | $7K | 34,301 |
| 2026-08-12 | Derakhshan Behrad Chief Business Officer | Sale | −2,475 | $43.70 | $108K | 31,826 |
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −2,839 | $43.78 | $124K | 15,227 |
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −2,779 | $43.71 | $121K | 12,448 |
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −104 | $44.43 | $5K | 12,344 |
| 2026-08-12 | Donovan Joanne M. CMO | Sale | −800 | $44.52 | $36K | 11,544 |
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −2,439 | $43.81 | $107K | 20,274 |
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −59 | $44.41 | $3K | 20,215 |
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −99 | $44.50 | $4K | 20,116 |
| 2026-08-12 | MOORE JOHN R General Counsel | Sale | −2,419 | $43.80 | $106K | 17,697 |
| 2026-08-12 | KOCH KEVIN President and CEO | Sale | −8,782 | $43.64 | $383K | 61,677 |
| 2026-08-12 | KOCH KEVIN President and CEO | Sale | −8,276 | $43.66 | $361K | 53,401 |
| 2026-08-12 | KOCH KEVIN President and CEO | Sale | −913 | $44.33 | $40K | 52,488 |
Page 1 of 8 · 146 trades